Back to User profile » Dr Toshiaki Kikuchi
Papers published by Dr Toshiaki Kikuchi:
Goal Attainment Scaling for Depression: Validation of the Japanese GAS-D Tool in Patients with Major Depressive Disorder
Kato M, Kikuchi T, Watanabe K, Sumiyoshi T, Moriguchi Y, Oudin Åström D, Christensen MC
Neuropsychiatric Disease and Treatment 2024, 20:49-60
Published Date: 16 January 2024
Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population
Kato M, Kikuchi T, Watanabe K, Sumiyoshi T, Moriguchi Y, Åström DO, Christensen MC
Neuropsychiatric Disease and Treatment 2023, 19:2401-2412
Published Date: 8 November 2023
Relationship Between Employment Status and Unstable Periods in Outpatients with Bipolar Disorder: A Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI) Study
Ikenouchi A, Konno Y, Fujino Y, Adachi N, Kubota Y, Azekawa T, Ueda H, Edagawa K, Katsumoto E, Goto E, Hongo S, Kato M, Tsuboi T, Yasui-Furukori N, Nakagawa A, Kikuchi T, Watanabe K, Yoshimura R
Neuropsychiatric Disease and Treatment 2022, 18:801-809
Published Date: 8 April 2022
Relationship Between Mood Episode and Employment Status of Outpatients with Bipolar Disorder: Retrospective Cohort Study from the Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Clinics (MUSUBI) Project
Konno Y, Fujino Y, Ikenouchi A, Adachi N, Kubota Y, Azekawa T, Ueda H, Edagawa K, Katsumoto E, Goto E, Hongo S, Kato M, Tsuboi T, Yasui-Furukori N, Nakagawa A, Kikuchi T, Watanabe K, Yoshimura R
Neuropsychiatric Disease and Treatment 2021, 17:2867-2876
Published Date: 7 September 2021
Brexpiprazole for the Treatment of Schizophrenia in Adults: An Overview of Its Clinical Efficacy and Safety and a Psychiatrist’s Perspective
Watanabe Y, Yamada S, Otsubo T, Kikuchi T
Drug Design, Development and Therapy 2020, 14:5559-5574
Published Date: 18 December 2020
Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)
Tsuboi T, Suzuki T, Azekawa T, Adachi N, Ueda H, Edagawa K, Katsumoto E, Kubota Y, Goto E, Hongo S, Watanabe Y, Kato M, Yasui-Furukori N, Yoshimura R, Nakagawa A, Kikuchi T, Watanabe K
Neuropsychiatric Disease and Treatment 2020, 16:881-890
Published Date: 31 March 2020
Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study
Otsubo T, Watanabe Y, Hongo S, Inoue M, Akimoto K, Murakami K, Takahashi R, Kikuchi T
Neuropsychiatric Disease and Treatment 2018, 14:955-966
Published Date: 6 April 2018
Associations among depression severity, painful physical symptoms, and social and occupational functioning impairment in patients with major depressive disorder: a 3-month, prospective, observational study
Harada E, Satoi Y, Kuga A, Tokuoka H, Kikuchi T, Watanabe K, Alev L, Mimura M
Neuropsychiatric Disease and Treatment 2017, 13:2437-2445
Published Date: 19 September 2017